✦ LIBER ✦

1209 POSTER ONX 0912, a Novel Oral Proteasome Inhibitor (PI), in Patients (pts) With Advanced Refractory or Recurrent Solid Tumours: a Phase 1, Open-label, Dose Escalation Study

✍ Scribed by K. Papadopoulos; D. Mendelson; A.W. Tolcher; H.A. Burris; M. Gordon; H. Wong; D. Bomba; S. Lee; H. Gillenwater; J. Infante

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

36 ORAL A Phase I single dose escalation

✍ P. Schöffski; A. Awada; H. Dumez; T. Gil; S. Bartholomeus; J. Selleslach; M. Tat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

605 A Phase 1, Open-label, Dose-escalati

✍ Burris, H.; Hart, L.; Kurkjian, C.; Berk, G.; Lipman, P.; Patel, C.; Rommel, C.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

394 A phase I dose escalation and pharma

✍ F. Eskens; L. van Doorn; D. Papadatos-Pastos; P. Debnam; M. Tall; M. Toal; L. Ho 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

414 POSTER A phase I, open-label, dose e

✍ M.S. Gordon; L.S. Rosen; F. Robert; D.S. Mendelson; D. Kleinzweig; B.J. Adams; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB